UNSPSC 51111749: Leurubicin

This classification denotes an anthracycline antibiotic with the molecular formula C33H40N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1Z20MGK851, chemically known as (8s,10s)-10-((3-((s)-2-amino-4-methylvaleramido)-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione but generally known as leurubicin, which bears US NIH Compound Identifier 68897.

UNSPSC 51111749 Leurubicin, a Commodity code, encompasses pharmaceutical products and related supplies procured by state and local health agencies. Recent opportunities tagged under this code show state and local governments buying pharmaceutical inventory and medical countermeasures through competitive bidding and cooperative purchasing vehicles, though the opportunities presented span a narrower range of actual drugs than the code name alone suggests.

Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 via Invitation for Bid for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets over a 12-month initial term with renewal options for years 2 and 3; Seminole County, Florida posted an IFB in June 2026 (response due July 26, 2026) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. State health departments and county health and emergency-management agencies are the primary issuing bodies. Geographic activity spans at least Florida and Illinois; the source does not support characterization of activity in other states or regions.